Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

New packaging solution ensures all take-home products are recyclable through most curb-side programsBELVIDERE, NJ, Feb. 13, ...

Belvidere-based Edible Garden is bringing something new to the table. After a successful pilot production, the hydroponic ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk ...